Search Results - "Losi, Serena"

The role of patient preferences in adherence to treatment in chronic disease: a narrative review by Losi, Serena, Berra, Cesare Celeste Federico, Fornengo, Riccardo, Pitocco, Dario, Biricolti, Giovanni, Orsini Federici, Marco

“…Adherence to prescribed medication is important to the management of all diseases, especially those of chronic nature. Drug effectiveness is substantially…”
Get full text

Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy by Ravasio, Roberto, Costanzo, Antonio, Antonelli, Silvia, Maiorino, Alessia, Losi, Serena

“…Interleukin (IL) inhibitors achieve greater levels of efficacy than older systemic therapies. We calculated the number needed to treat (NNT) of ixekizumab…”
Get full text

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib by Perrone, Valentina, Losi, Serena, Rogai, Veronica, Antonelli, Silvia, Fakhouri, Walid, Giovannitti, Massimo, Giacomini, Elisa, Sangiorgi, Diego, Degli Esposti, Luca

“…Introduction The objective of this study was to evaluate treatment patterns in patients with rheumatoid arthritis (RA), with a focus on the utilization of…”
Get full text

Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy by Ravasio, Roberto, Antonelli, Silvia, Maiorino, Alessia, Costanzo, Antonio, Losi, Serena

“…This analysis was aimed at estimating the cost per responder as measured by number needed to treat of ixekizumab as compared with other biologic drugs approved…”
Get full text

Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy by Ravasio, Roberto, Antonelli, Silvia, Rogai, Veronica, Fakhouri, Walid, Capron, Jean Philippe, Losi, Serena

“…Biological disease-modifying antirheumatic drugs are recommended for use particularly in rheumatoid arthritis patients who had an inadequate response to…”
Get full text

ansa-Nickelocenes by the Ring-Closing Metathesis Route:  Syntheses, X-ray Crystal Structures, and Physical Properties by Buchowicz, Włodzimierz, Jerzykiewicz, Lucjan B, Krasińska, Anna, Losi, Serena, Pietrzykowski, Antoni, Zanello, Piero

“…The first ansa-nickelocenes, [Ni(η5,η5-C5H4−CH2−CHCH−CH2−C5H4)] (4) and [Ni(η5,η5-C5H4−(CH2)2−CHCH−(CH2)2−C5H4)] (5), and a bridged binickelocene,…”
Get full text

Preparation, Structure and Reactivity of Polynuclear Gold(I) Phosphanyl Alkanethiolates by Battisti, Antonella, Bellina, Oliver, Diversi, Pietro, Losi, Serena, Marchetti, Fabio, Zanello, Piero

“…The homoleptic gold(I) thiolates of formula [Au(SR)]n (R = CMe3, CH2CMe3, CH2CHMe2, CPh3) have been converted into their phosphane derivatives of general…”
Get full text

Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study by Perrone, Valentina, Losi, Serena, Filippi, Erica, Antonelli, Silvia, Giovannitti, Massimo, Giacomini, Elisa, Sangiorgi, Diego, Degli Esposti, Luca

“…To evaluate the prevalence of ankylosing spondylitis (AS) and associated treatment patterns and drug utilization in real-world clinical practice in Italy. This…”
Get more information

Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings by Perrone, Valentina, Losi, Serena, Rogai, Veronica, Antonelli, Silvia, Fakhouri, Walid, Giovannitti, Massimo, Giacomini, Elisa, Sangiorgi, Diego, Degli Esposti, Luca

“…This study aimed to evaluate the treatment patterns and pharmacoutilization of patients with rheumatoid arthritis (RA) in real-world settings in Italy. This…”
Get full text

Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population by Perrone, Valentina, Losi, Serena, Filippi, Erica, Mezzetti, Maurizio, Dovizio, Melania, Sangiorgi, Diego, Degli Esposti, Luca

“…Introduction Real-world pharmacoutilization analysis of biological drugs in psoriatic arthritis (PsA) patients with the aim to evaluate biologic treatment…”
Get full text

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study by Federici, Marco Orsini, McQuillan, Janette, Biricolti, Giovanni, Losi, Serena, Lebrec, Jeremie, Richards, Catrina, Miglio, Cristiana, Norrbacka, Kirsi

“…Introduction Real-world evidence on glucagon-like peptide-1 receptor agonist (GLP-1 RAs) usage is emerging in different European countries but is lacking in…”
Get full text

Treatment Patterns and Pharmacoutilization in Patients Affected by Psoriasis: An Observational Study in an Italian Real-World Setting by Perrone, Valentina, Losi, Serena, Maiorino, Alessia, Antonelli, Silvia, Giovannitti, Massimo, Giacomini, Elisa, Sangiorgi, Diego, Degli Esposti, Luca

“…Background Real-world data can inform the use of biologics for psoriasis (PSO). Objective The aim was to evaluate treatment patterns and analyze…”
Get full text

New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review by Caporali, Roberto, Fakhouri, Walid K. H., Nicolay, Claudia, Longley, Harriet J., Losi, Serena, Rogai, Veronica

“…Introduction In the last 20 years, biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) have become available for treating rheumatoid…”
Get full text

Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy by Boye, Kristina S, Matza, Louis S, Stewart, Katie D, Jordan, Jessica, Biricolti, Giovanni, Del Santo, Silvia, Perez-Nieves, Magaly, Federici, Marco O, Gentilella, Raffaella, Losi, Serena, Norrbacka, Kirsi

“…Several glucagon like peptide-1 (GLP-1) receptor agonists are available as weekly injections for treatment of type 2 diabetes. These medications vary in their…”
Get more information

Drug target insights by Losi, Serena, Berra, Cesare Celeste Federico, nengo, Riccardo, Pitocco, Dario, Biricolti, Giovanni, Federici, Marco Orsini

Get full text

Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns by Kleyn, C. Elise, Barbarot, Sébastien, Reed, Catherine, Losi, Serena, von Arx, Lill-Brith, Robert, Camille, Anderson, Peter, Grond, Susanne, Costanzo, Antonio

“…Introduction Moderate to severe atopic dermatitis (AD) is associated with a significant disease burden, impacting sleep, quality of life, and treatment needs…”
Get full text

Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy by Ravasio, Roberto, Antonelli, Silvia, Maiorino, Alessia, Costanzo, Antonio, Losi, Serena

Get full text

Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population by Perrone, Valentina, Losi, Serena, Sabatino, Silvia, Mezzetti, Maurizio, Dovizio, Melania, Sangiorgi, Diego, Degli Esposti, Luca

“…An Italian real-world retrospective study was conducted in patients with psoriasis (PSO) to evaluate their characteristics, treatment patterns, and…”
Get full text

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy by Matza, Louis S., Osumili, Beatrice, Stewart, Katie D., Perez-Nieves, Magaly, Jordan, Jessica, Biricolti, Giovanni, Romoli, Ester, Losi, Serena, Del Santo, Silvia, Spaepen, Erik, Parola, Gordon, Karn, Hayley, Boye, Kristina S.

“…Introduction Standard concentration (100 units/mL) mealtime insulin is frequently used to treat patients with type 1 (T1D) and type 2 diabetes (T2D). A more…”
Get full text

Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy by Ravasio, Roberto, Antonelli, Silvia, Rogai, Veronica, Fakhouri, Walid, Capron, Jean Philippe, Losi, Serena

Get full text